Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease
Near-infrared fluorescence (NIRF) molecular imaging has been widely applied to monitoring therapy of cancer and other diseases in preclinical studies; however, this technology has not been applied successfully to monitoring therapy for Alzheimer’s disease (AD). Although several NIRF probes for detec...
Main Authors: | Zhang, Xueli, Tian, Yanli, Zhang, Can, Tian, Xiaoyu, Ross, Alana W., Moir, Robert D., Sun, Hongbin, Tanzi, Rudolph E., Moore, Anna V., Ran, Chongzhao |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2016
|
Online Access: | http://hdl.handle.net/1721.1/101113 |
Similar Items
-
Non-Conjugated Small Molecule FRET for Differentiating Monomers from Higher Molecular Weight Amyloid Beta Species
by: Ran, Chongzhao, et al.
Published: (2011) -
Alternatives to amyloid for Alzheimer's disease therapies—a symposium report
by: Cable, Jennifer, et al.
Published: (2021) -
Molecular docking studies on the interaction of anti-alzheimer compounds with amyloid beta peptides
by: Faujan, Nur Hana, et al.
Published: (2019) -
Mechanistic studies of beta protein amyloid formation in Alzheimer's disease : identification and characterization of protofibril intermediates
by: Harper, James D. (James Douglas), 1971-
Published: (2009) -
Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
by: Høilund-Carlsen, Poul F., et al.
Published: (2024)